Qiming-Backed AI Drug Discovery Startup Insilico Medicine Hits Unicorn Status With 110 Million Funding Round

Get the Full StoryInsilico Medicine, whose Hong Kong IPO application lapsed in 2024, is still considering going public in the city, said founder Alex Zhavoronkov.

Share: